Gainers
- CohBar CWBR stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The company's, Q2 earnings came out yesterday.
- Fulcrum Therapeutics FULC stock increased by 10.76% to $20.79. The market value of their outstanding shares is at $679.4 million. The company's, Q2 earnings came out yesterday.
- Allied Healthcare Prods AHPI shares rose 9.3% to $11.75. The company's market cap stands at $47.1 million.
- BioCryst Pharmaceuticals BCRX shares moved upwards by 8.05% to $16.43. The company's market cap stands at $2.9 billion. The company's, Q2 earnings came out 4 days ago.
- Hoth Therapeutics HOTH shares rose 7.08% to $1.36. The market value of their outstanding shares is at $32.4 million.
- Aditxt ADTX shares moved upwards by 6.82% to $2.38. The market value of their outstanding shares is at $34.9 million.
Losers
- Arcturus Therapeutics ARCT stock decreased by 7.91% to $46.58 during Wednesday's pre-market session. The company's market cap stands at $1.2 billion. As per the news, the Q2 earnings report came out 2 days ago.
- Nuwellis NUWE stock fell 7.4% to $4.26. The company's market cap stands at $27.8 million. As per the news, the Q2 earnings report came out yesterday.
- Talis Biomedical TLIS shares decreased by 7.25% to $8.32. The market value of their outstanding shares is at $213.3 million. As per the press release, Q2 earnings came out yesterday.
- Inari Medical NARI shares decreased by 6.65% to $83.0. The company's market cap stands at $4.1 billion. As per the press release, Q2 earnings came out yesterday.
- Altimmune ALT stock decreased by 6.26% to $10.2. The company's market cap stands at $391.6 million. As per the press release, Q2 earnings came out yesterday.
- Allena Pharmaceuticals ALNA shares fell 5.48% to $0.91. The market value of their outstanding shares is at $68.3 million. As per the press release, Q2 earnings came out yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in